Restricting K-M OS survival analyses to AML patients with distinct mutations revealed that upregulated levels of NDUFA6, SDHA and CPT1A were associated with unfavourable prognosis in mutated IDH1 AML patients (Table 3). The gene discussed is IDH1; the disease is acute myeloid leukemia.